FOXO TechnologiesFOXO
About: FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life.
Employees: 168
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
180% more capital invested
Capital invested by funds: $64.7K [Q3] → $181K (+$117K) [Q4]
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
42% more funds holding
Funds holding: 12 [Q3] → 17 (+5) [Q4]
0.85% more ownership
Funds ownership: 2.43% [Q3] → 3.28% (+0.85%) [Q4]
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Research analyst outlook
We haven’t received any recent analyst ratings for FOXO.
Financial journalist opinion









